# EXOZYMES INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/exozymes-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 8 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:45:26.184528+00:00 | | Last reviewed | 2026-10-19T14:45:26.184528+00:00 | ## Identity - Legal name: EXOZYMES INC. - Display name: EXOZYMES INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T19:24:39.622523+00:00 | | Completeness | 0.409 | | Record Quality | 0.838 | | Directors | 6 | | Committees | 5 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anthony DiGiandomenico: Director. Status: current. Independent: false. Since: 2019-01-01. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:5 - Christopher A. Marlett: Director. Status: current. Independent: false. Since: 2019-01-01. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:6 - Edgardo Rayo: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:7 - James J. Lalonde: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8 - James U. Bowie: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9 - Lon E. Bell: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10 ## Committees - Audit (audit). Chair: Lon E. Bell. Members: Lon E. Bell (chair, current); James J. Lalonde (member, current); James U. Bowie (member, current). committee_id=alpha:committee:exozymes-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Lon E. Bell (member, current). committee_id=alpha:committee:exozymes-inc:audit-chair-compensation-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: James J. Lalonde (member, current); James U. Bowie (member, current). committee_id=alpha:committee:exozymes-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: James J. Lalonde (member, current); James U. Bowie (member, current); Lon E. Bell (member, current). committee_id=alpha:committee:exozymes-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: James J. Lalonde (member, current); James U. Bowie (member, current); Lon E. Bell (member, current). committee_id=alpha:committee:exozymes-inc:nominating-and-governance ## Executive leadership - Damien Perriman: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:11 - Fouad Nawaz: Vice President, Finance. Status: current. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:12 - Michael Heltzen: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:13 - Paul Opgenorth: Vice President, Development. Status: current. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:14 - Tyler Korman: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:15 ## Governance events - EXECUTIVE_APPOINTED: Damien Perriman executive of EXOZYMES INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:e0mwyx1pjes13 - EXECUTIVE_APPOINTED: Fouad Nawaz executive of EXOZYMES INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:rsf5j619p8c8y - CEO_CHANGED: Michael Heltzen executive of EXOZYMES INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1nchgvfee8ipr - EXECUTIVE_APPOINTED: Paul Opgenorth executive of EXOZYMES INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1d7q65kum7s74 - EXECUTIVE_APPOINTED: Tyler Korman executive of EXOZYMES INC., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:65dug511vl1pj - DIRECTOR_APPOINTED: Edgardo Rayo seat on EXOZYMES INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:fiqova18j04q0 - DIRECTOR_APPOINTED: James J. Lalonde seat on EXOZYMES INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1wqzydw1ike5na - DIRECTOR_APPOINTED: Lon E. Bell seat on EXOZYMES INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:9mj1cr1hljslv - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of EXOZYMES INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:4cdc9tj2nsjr - COMMITTEE_MEMBER_ADDED: Lon E. Bell member of Audit · Chair; Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:fbhpk01cqmen0 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of EXOZYMES INC., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1klnzl2c8826a - COMMITTEE_MEMBER_ADDED: James J. Lalonde member of Audit; Compensation; Nominating and Governance, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1x2jjnl1d0479t - DIRECTOR_APPOINTED: Anthony DiGiandomenico seat on EXOZYMES INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1biupud1vmjvm1 - DIRECTOR_APPOINTED: Christopher A. Marlett seat on EXOZYMES INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:aksw9ihs36oi - DIRECTOR_APPOINTED: James U. Bowie seat on EXOZYMES INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:koefjb1enjh4h - COMMITTEE_MEMBER_ADDED: James U. Bowie member of Audit; Compensation; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-19T14:45:26.184528+00:00. event_id=alpha:event:transition:1wg9uownmhnka ## Scoped resources - `alpha://company/exozymes-inc` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record - `alpha://company/exozymes-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=identity - `alpha://company/exozymes-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=corporate-structure - `alpha://company/exozymes-inc/board` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=board - `alpha://company/exozymes-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=committees - `alpha://company/exozymes-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=leadership - `alpha://company/exozymes-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=ownership - `alpha://company/exozymes-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=financials - `alpha://company/exozymes-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=capital-structure - `alpha://company/exozymes-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=compensation - `alpha://company/exozymes-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=governance - `alpha://company/exozymes-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=shareholder-governance - `alpha://company/exozymes-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=audit - `alpha://company/exozymes-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=legal - `alpha://company/exozymes-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=risk - `alpha://company/exozymes-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=cyber - `alpha://company/exozymes-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=ai-governance - `alpha://company/exozymes-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=agents - `alpha://company/exozymes-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=ecosystem - `alpha://company/exozymes-inc/events` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=events - `alpha://company/exozymes-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=relationships - `alpha://company/exozymes-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=assessments - `alpha://company/exozymes-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:lon-e-bell","name":"Lon E. Bell"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-j-lalonde","name":"James J. Lalonde"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:james-u-bowie","name":"James U. Bowie"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:james-j-lalonde","name":"James J. Lalonde"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:james-u-bowie","name":"James U. Bowie"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lon-e-bell","name":"Lon E. Bell"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:james-j-lalonde","name":"James J. Lalonde"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:james-u-bowie","name":"James U. Bowie"},"source_id":"board_seats"}` - Claim alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lon-e-bell","name":"Lon E. Bell"},"source_id":"board_seats"}` ## Leadership - Anthony DiGiandomenico: Director. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:5. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - Christopher A. Marlett: Director. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:6. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - Edgardo Rayo: Director. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - James J. Lalonde: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - James U. Bowie: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - Lon E. Bell: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d. - Damien Perriman: Chief Commercial Officer. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:11. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:19cb93ab6bbc27b1a4d9f16bba67a45c9d610dde598f0547c1ad9c8ee837ea20. - Fouad Nawaz: Vice President, Finance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:12. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ca5e1051be2c2d98e9d3035b286aa504042adf028571bf979730773b615da226. - Michael Heltzen: President and Chief Executive Officer. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:13. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0a1cdb481a351b00b8931377455a3da8c95a6d6fa0f1cbbce070eda76539fbea. - Paul Opgenorth: Vice President, Development. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:14. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:82d3ae83724a105eed93aa6119be0b4fb442acebe1a9a7c86b0fa2bf15d53b24. - Tyler Korman: Chief Scientific Officer. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:15. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0e410682ed7c3dc838c488dec57a87723cca9224a9fb7228ee5708f683831657. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Lon E. Bell; Members Lon E. Bell (Chair); James J. Lalonde; James U. Bowie. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - Compensation: Chair not stated; Members James J. Lalonde; James U. Bowie; Lon E. Bell. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - Nominating and Governance: Chair not stated; Members James J. Lalonde; James U. Bowie; Lon E. Bell. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - EXOZYMES INC.. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ab6335fa23b9fd87e92fcc7cd84114567c071f0862e67f85fa3af68f0afd81a7. ## Entity Status - Public listing published. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ab6335fa23b9fd87e92fcc7cd84114567c071f0862e67f85fa3af68f0afd81a7. ## Published Fact - US. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ab6335fa23b9fd87e92fcc7cd84114567c071f0862e67f85fa3af68f0afd81a7. ## Committee Appointment - Lon E. Bell: chair, Audit. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James J. Lalonde: member, Audit. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James U. Bowie: member, Audit. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James J. Lalonde: member, Compensation. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James U. Bowie: member, Compensation. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - Lon E. Bell: member, Compensation. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James J. Lalonde: member, Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - James U. Bowie: member, Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. - Lon E. Bell: member, Nominating and Governance. Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f. ## Security Listing - EXOZ (NASDAQ). Claim: alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ab6335fa23b9fd87e92fcc7cd84114567c071f0862e67f85fa3af68f0afd81a7. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:ab6335fa23b9fd87e92fcc7cd84114567c071f0862e67f85fa3af68f0afd81a7: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/exozymes-inc). - alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d: [EXOZYMES INC. DEF 14A 2025-06-20](https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm). - alpha:projection-evidence:document:19cb93ab6bbc27b1a4d9f16bba67a45c9d610dde598f0547c1ad9c8ee837ea20: [EXOZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm). - alpha:projection-evidence:document:ca5e1051be2c2d98e9d3035b286aa504042adf028571bf979730773b615da226: [EXOZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm). - alpha:projection-evidence:document:0a1cdb481a351b00b8931377455a3da8c95a6d6fa0f1cbbce070eda76539fbea: [EXOZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm). - alpha:projection-evidence:document:82d3ae83724a105eed93aa6119be0b4fb442acebe1a9a7c86b0fa2bf15d53b24: [EXOZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm). - alpha:projection-evidence:document:0e410682ed7c3dc838c488dec57a87723cca9224a9fb7228ee5708f683831657: [EXOZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm). - alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f: [Audit](https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/exozymes-inc) - [Public Markdown](https://registry.alpha.ac/companies/exozymes-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/exozymes-inc?format=jsonld) - MCP resource: `alpha://companies/exozymes-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T19:24:39.39864+00:00; recorded 2026-10-19T19:24:39.39864+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.